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Article title 
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Keywords 
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Structured Abstract 
Objective 
This study explores whether the profile of patients’ interactional behaviour in memory 
clinic conversations with a doctor can contribute to the clinical differentiation between 
functional memory disorders (FMD) and memory problems related to 
neurodegenerative diseases.  
Methods 
Conversation Analysis of video recordings of neurologists’ interactions with patients 
attending a specialist memory clinic. “Gold standard” diagnoses were made 
independently of CA findings by a multi-disciplinary team based on clinical 
assessment, neuropsychological testing and brain imaging. 
Results 
Two discrete conversational profiles for patients with memory complaints emerged, 
including i) who attends the clinic (i.e. whether or not patients are accompanied), and 
ii) patients’ responses to neurologists' questions about memory problems, such as 
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difficulties with compound questions  and providing specific and elaborated 
examples and frequent "I don't know" responses.  
Conclusion 
Specific communicative difficulties are characteristic of the interaction patterns of 
patients with a neurodegenerative pathology. Those difficulties are manifest in 
memory clinic interactions with neurologists, thereby helping to differentiate patients 
with dementia from those with FMD. 
Practical implications 
Our findings demonstrate that conversation profiles based on patients’ contributions 
to memory clinic encounters have diagnostic potential to assist the screening and 
referral process from primary care, and the diagnostic service in secondary care.  
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1.  Introduction/Background  
The clinical differentiation of memory complaints attributable to progressive 
neurodegenerative disorders leading to dementia (ND) and that of similar complaints 
due to functional memory disorders (FMD, i.e. non-progressive memory deficits) [1] 
is a frequent challenge in specialist memory clinics. Recent observations in the 
United Kingdom (UK) suggest that up to 50% of patients referred to memory clinics 
are diagnosed with FMD rather than memory complaints secondary to ND [2]. 
Previous research shows that distinguishing ND from FMD is associated with high 
rates of diagnostic errors [1].  This is particularly true when diagnosis is attempted at 
the earliest stages of possibly progressive memory disorders. However, an early 
differentiation of ND from FMD is highly desirable from a therapeutic point of view 
and has been declared a particular health service priority by the UK government [3, 
4]. 
Clinical differentiation of cognitive symptoms due to neurodegenerative dementia, 
especially early stage Alzheimer’s Disease (AD), is still difficult due to a lack of 
reliable biomarkers.  There is some evidence, however, that analysis of patients’ 
language may contribute to detecting dementia risk in patients with mild cognitive 
impairment [5-7], in sponaneous writing [8-10], and spontaneous speech [11, 12]. 
Language impoverishment through grammatical simplification, loss of vocabulary, 
semantic paraphasias, and overuse of semantically empty words is progressively 
evident in dementia [13, 14]. However, detection of such linguistic impoverishment i) 
requires complex linguistic analysis, ii) may be diagnostically ambiguous, and iii) 
does not yet take account of more directly observable conversational/communicative 
features of patients’ interactions.  
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The assessment of a patient’s memory concerns typically begins with history-taking, 
complemented by neuropsychological testing and brain scanning (Magnetic 
Resonance Imaging (MRI) or Computerised tomography (CT)). It is widely 
recognised that reliance on tests alone increases the rate of erroneous diagnoses 
[1]. Although the patient's history is a key to diagnosis and to choosing an 
appropriate treatment strategy, the interaction between doctor and patient, central to 
the diagnostic process of memory problems, has received relatively little research 
attention. 
The purpose of this study was to explore patient interaction as a diagnostically 
relevant resource to differentiate organic (i.e. ND) and non-organic causes of 
memory complaints [15]. Building on previous work exploring the use of 
Conversation Analysis (CA) as a diagnostic aid in the seizure clinic [16-18], and an 
initial analysis of a small subset of our corpus of recordings from the memory clinic 
[19], the present study focused on patients’ participation in initial clinical encounters 
with neurologists, to investigate the potential of using conversational features to 
distinguish memory complaints related to functional causes from those caused by 
ND. 
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2. Methods 
2.1  Study design 
The study design parallels prior research that identified, described and tested 
profiles of interactional, linguistic and topical features as aids in the differential 
diagnosis of patients with epilepsy or psychogenic non-epileptic seizures [16-18]. 
Using similar analytic methods, we aimed to distinguish between conversational 
patterns observable in interactions with patients whose memory complaints are due 
either to ND (such as Alzheimer’s disease) or FMD. FMD diagnostic criteria were 
suggested by Schmidtke et al. [20]; for a more extensive discussion of the nature of 
FMD, and the differences between FMD, Mild Cognitive Impairment (MCI) and 
Subjective Memory Complaints, see [1]. Participating patients were screened for 
depression using the Patient Health Questionnaire 9 (PHQ9) [21]. However, a past 
history of depression and current dysthymia were not exclusion criteria. Depression 
is known to be a contributory cause of cognitive difficulties, and dementia and 
depression can often be associated; mood screening was, therefore, conducted in 
order to control this by exclusion. 
2.1.1 Patient recruitment  
Between October 2012 and October 2014, a total of 99 patients initially presenting to 
the memory clinic in the Department of Neurology at the Royal Hallamshire Hospital, 
Sheffield, United Kingdom, were video recorded. Patients had been referred to the 
neurology-led memory clinic service, from the area covered by the South Yorkshire 
Health Authority. The majority of referrals were from primary care, but others from 
non-specialist neurologists and psychiatrists were also accepted. Appointment letters 
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to patients routinely encouraged them to bring along a family member, friend or carer 
to the clinic.  
2.1.2 Diagnostic process 
Patients were provisionally diagnosed following their assessment by a specialist 
consultant neurologist and completion of the Addenbrooke’s Cognitive Examination 
(ACE-R, a 20 minute screening tool). Final ‘gold standard’ clinical diagnosis was 
reached by interdisciplinary consensus based on history, extensive 
neuropsychological testing and magnetic resonance imaging (MRI) of the brain. 
Pathological confirmation of clinical diagnoses was not available within the timeframe 
of this study. 
The neuropsychological battery included the Mini Mental State Examination [22], 
tests of short and long term memory (verbal and non-verbal) [23, 24], tests of 
abstract reasoning [24, 25] and tests of attention and executive function [26], tests of 
language comprehension [27], naming by confrontation, and category and letter 
fluency. Neuropsychological testing [28] is routinely administered to patients 
attending this clinic, and was especially important for this study which required a 
‘gold standard’ clinical diagnosis for all patients recruited. Patients were screened for 
anxiety using the Generalised Anxiety Disorder 7 questionnaire [29]. 
2.1.3 Neurologists’ questioning 
Analysis focused on the opening history-taking phase of the memory clinic visit, 
preceding more formal cognitive tests (e.g. ACE-R). There was no intervention in the 
normal conduct of history-taking, except that to ensure comparability neurologists 
were reminded to cover fully the conventionally required questions in each interview. 
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These included asking patients for as full an account as possible of their memory 
difficulties, including specific examples of when and how their memory had let them 
down, and questions about who was most concerned about their memory difficulties 
and their expectations of the visit. 
2.1.4 Data corpus - Participant details 
A total of 30 cases were included in the analysis; 15 of these patients received an 
ultimate clinical diagnosis of FMD, 15 were diagnosed with ND (11 with early 
dementias, 4 with amnestic MCI highly likely to develop into dementia) (see table 1 
for more patient details).  For present purposes we focused only on patients who 
satisfied the relevant 'gold standard' diagnostic criteria; other cases were not 
included because patients did not fulfil published criteria either for FMD [20] nor ND 
[30, 31].  Excluded cases included instances of depressive pseudo-dementia, 
cognitive disorders due to other psychiatric conditions, and significant cognitive 
disorders due to other neurological conditions but not neurodegeneration. 
 
Table 1  
 
Non-parametric statistics were performed on demographic variables (age and 
education level) and on mood scales (PHQ-9 [21] and GAD-7 (see [29])). There were 
no significant differences between the two groups on these variables. A chi-square 
test was carried out to ascertain whether the number of patients who came 
accompanied in the ND and FMD groups differed; the ND group were significantly 
more likely to be accompanied than the FMD group (p<0.008). See Table 1 for the 
details of these results. 
2.2 Conversation Analysis  
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The data were analysed using the perspective and methods of CA, to investigate the 
temporal and sequential real-time progress of interaction (including verbal and non-
vocal conduct), and identify the systematic patterns and practices through which 
participants understand one another [e.g. 32, 33-35]. CA has been applied 
successfully to doctor-patient interactions, focusing particularly on their interactional 
structure, dynamics and organisation, to inform and direct medical practice and 
diagnosis [17, 36, 37]. Video recordings provide access to non-verbal features of 
interactions, which can be vital when investigating and understanding embodied 
features such as the 'head-turning sign' previously linked to Alzheimer's disease [38-
40].  
The video recordings were transcribed in accordance with the conventions devised 
by Jefferson [41], capturing real-time features of the talk and widely used in CA 
research. The qualitative video data management software Transana [42] was 
utilised to organise, compare and analyse cases across the entire video corpus. This 
software facilitated populating the analytic categories that were being identified 
across the corpus and within the different diagnostic classifications, which developed 
into the collections outlined in this paper. 
The differential conversational profiles of the two diagnostic groups were established 
through the following methodology. The diagnosis for each patient was made by the 
clinical team by multidisciplinary consensus, using the clinical interview, 
neuropsychological tests and findings from neuroimaging investigations. The history-
taking interactions were then reviewed in order to identify conversational factors or 
patterns which clustered in one or the other diagnostic group, and which thereby 
contributed to the conversational profile of each group (this study design and 
methodology follows that reported in [16-18]). Although the role of companions 
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(when present) is being investigated and will be reported in future papers, for present 
purposes we focus only on when and how accompanying persons feature in the 
patients' talk. For instance, a patient might suggest that their companion is better 
placed to provide certain information ("I can't really remember half of what's...you're 
better off asking me husband. He'll probably give yah a lot more information").  
2.3  Ethics 
The study was approved by the NHS Research Ethics Committee (NRES Committee 
Yorkshire & The Humber - South Yorkshire). The recruited patients received written 
information about the study at least 48 hours prior to their appointment and were 
encouraged to discuss the information provided with anyone they wanted to bring 
along to the clinic visit. On the day of the visit, they had the opportunity to speak to a 
member of the research team prior to their appointment. Participants gave written 
informed consent, having been told that they could withdraw from the study at any 
time. Patients lacking capacity to consent were excluded from the study. 
Confidentiality was assured and transcripts were pseudo-anonymised of participants’ 
identifiers in any subsequent outputs.  
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3.Results 
We identified working conversational profiles that distinguished between the two 
patient groups, i.e. patients with memory complaints due to ND and patients with 
FMD. Broadly the profile is separated into two areas: who attends the memory clinic, 
and how patients respond to neurologists' questions during history-taking.  
3.1  Accompanying persons 
Whilst patients were routinely encouraged to attend the clinic accompanied by a 
relative or friend, not all patients did so. An early (and therefore provisional) 
indication of a patient's eventual diagnosis is whether or not they were 
accompanied (typically by at least one family member). In the dementia subset 10 
out of 11 (91%) were accompanied, whereas only 6 out of 15 (40%) of patients with 
FMD were joined in the consultation (see table 1). This differentiating feature is 
consistent with the findings of previous research [43, 44].  
We then considered how patients involved accompanying persons (APs) in their 
attempts to answer neurologists’ questions, and generally in giving an account of 
their memory problems [15, 45]. It is clear that from time to time, most frequently in 
interviews with ND patients, APs often acted as spokespersons for patients, for 
instance by providing information about the difficulties the patient had experienced. 
Figure 1, taken from the opening exchanges of a patient with a ND, is a clear 
example of an AP’s contribution to his spouses' consultation. 
 
Figure 1  
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Here the neurologist asks two direct questions. It is evident that the AP treats the 
delay in response (the silence in line 3) as indicating that the patient might have 
trouble in responding and therefore steps in to answer on the patient's behalf. Such 
interjections occurred only in the interviews of patient's with ND; there were no 
comparable instances in the FMD subset.  
However, these contributory interventions by APs remain to be analysed further; we 
focused instead on how patients involve APs in the interactions. In the next 
example, from a consultation with a patient with FMD, AP’s contribution follows a 
rather different pattern. The AP only contributes (non-verbally) when requested to do 
so by the patient (again tacitly through turning towards her as a confirmation check in 
line 3). 
 
Figure 2  
 
This example illustrates the different shape that characterised triadic encounters 
involving patients with FMD; the AP's role was to act as a resource available to the 
patients when they wanted to check the accuracy of their responses (referred to here 
as confirmation checks), as well as when seeking a second opinion. 
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3.2 Responding to neurologists' questions about memory problems 
Patients were regularly (n=14, out of 26 consultations) asked "Who is most 
concerned about the memory problems?" (or some variation) [46, 47]. A clear 
distinction emerged in the responses given by FMD and ND patients. In all 9 of the 
FMD cases in which the question was asked, the patient stated that they were the 
one most concerned ("[It's] me"). Note that attending alone might also be related to 
this. In the most transparent case, an FMD patient expands his utterance, saying 
"My partner dun't even know I'm `ere. (2.0) I've not even discussed it with 
him...((continues discussing his anxieties))". 
In contrast, the same question yielded a very different response from the patients 
with dementia; in 4 of the 5 cases the AP said they were both more aware of and 
concerned about the memory problems (e.g. "I got her to see the GP..." in case 048). 
Furthermore, there was evidence to suggest that the patients themselves were not 
aware of any problems or could not answer the question, sometimes failing to reply 
altogether (e.g., "I don't know" in case 033, which the AP responded to by saying 
"Well I am certainly worried about it" registering her position).  
3.3 Patient recall of recent memory failure 
In 17 of the 26 cases analysed the neurologist asked the patient to give an example 
of the most recent time their memory let them down ("Can you give me an example 
of the last time your memory let you down?", or some variant thereof). In 11 of 
the 12 occasions from the FMD category when this question was asked, the patient 
successfully provided a relevant and detailed example of a particular recent event, 
as illustrated in Figure 3.  
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Figure 3  
 
In contrast the ND patients had difficulty answering this question and giving such an 
example (see Small and Perry on the difficulties surrounding episodic memory for 
Alzheimer's patients [47]). Most either made no response, or only the beginnings of a 
response (e.g., "um" or "er"), or declared they were unable to remember a specific 
occasion. In 2 cases the patient sought the assistance of the AP ("can you?"). In the 
few cases when patients from this group responded, the 'example' offered was a 
routine or common problem, rather than a specific incident (e.g., "happens all the 
time" or "it's daily").  
3.4  Responding to compound questions 
The majority of neurologists’ questions were mono-topical (e.g. "can you tell me the 
last time it happened to you?" in Figure 3 above). However, they sometimes asked 
compound questions consisting of two or more items/questions (for an account of the 
conversational affordances associated with compound constructions see [19, 48]). 
An example occurs in Figure 1 above, when the neurologist asks "Do you know the 
reasons why you've been referred to this clinic and, and who's more concerned?". 
The two patient groups responded differently to multi-component, compound 
questions. 
FMD patients were able to attend to multiple parts of a question (e.g. "can you tell 
me a little bit about your background, where you're from originally and where did you 
go to college") in their responses and could return to other elements of the initial 
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question after providing detailed answers to aspects of it (see also [19]). In contrast, 
ND patients experienced difficulties, frequently replying to single components of the 
compound questions, and were unable to recall and respond to other aspects of the 
original question, so that the neurologist was required to repeat the omitted parts of 
the question. This is evident in Figure 4. 
 
Figure 4  
 
The patient answers the first part of the question about reading, but after the 27 
omitted lines, seems unable to recover the second and third items in the original 
question - items that the neurologist therefore repeats (line 7). For a more detailed 
exposition of ND patients' difficulties responding to compound questions see Jones 
et al. [19]. 
3.5 Inability to answer 
Previous research by Mikesell [49] into patients with frontotemporal dementia 
highlighted the frequency with which they did ‘not know’ answers to questions about 
matters they would be expected to know/remember, such as personal issues [47, 
50]. Our study develops these findings by identifying equivalent ways in which 
patients indicate they are unable to answer such questions, as well as answering 
that they ‘do not know’ (i.e. cannot remember). 
FMD patients responded verbally with "I don't know" only rarely (four times in 15 
cases), each in response to questions about their "expectations" for the visit. On 
another 4 occasions FMD patients indicated non-verbally that they didn't know, by 
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turning to their AP for assistance. Whether patients indicated their inability to answer 
verbally or non-verbally, they conveyed that they were unsure because they had not 
previously considered the matter, rather than being unable to recall.   
However, ND patients displayed a different pattern of response, indicating 
specifically an inability to remember. In the clinical interviews with 11 ND patients 
there were 45 responses indicating that they could not recall, whether verbally (29 
cases) or embodied in the form of 'head turning' signs (16 cases, illustrated below). 
The results of non-parametric tests (Fischer's exact) show that there is a significant 
difference in the number of verbal 'I don't know' responses (p<0.004) but not for 
head turning or other non-verbal forms (p=0.103). 
Such problems recalling information is exemplified by the following sequence (Figure 
5). 
 
Figure 5  
 
The patient’s difficulty recalling her travels are evident in her responses in line 3, 6 
and 10 (and non-response in line 14); however her response “not offhand” (line 23) 
most clearly indicates difficulties recalling matters that she might be expected to 
remember.  
Previous studies have noted a high incidence of head-turns in patients with dementia 
[38-40]. The prevalence of head-turning indicates recall difficulties and 
conversational problems in general. ND patients frequently defer questions to their 
companions to fill in their memory gaps [46, 51, 52]. 
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A typical example is provided in Figure 6 below. 
 
Figure 6 
 
Notice the lengthy pauses in lines 3 and 5, in conjunction with the patient’s turn to 
AP1 in line 4 display that he "didn't know how to answer".  
3.6 Patients' elaborations and length of turns 
FMD patients often elaborated their responses by volunteering unsolicited details 
when responding to relatively closed questions (example given in Figure 7).  
 
Figure 7 
 
The patient's response in Figure 7 goes beyond the original question by explaining 
where she grew up and studied at university. This additional material is appropriate 
and relevant to the topic at hand. This kind of expansion or elaboration by the patient 
is very common in the FMD consultations, but was rarely seen in the ND group [47]. 
The fundamental difference between the patient groups was that the ND patients 
were generally unable to go beyond the (literal) parameters of the question as 
demonstrated in Figure 8.  
 
Figure 8 
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Briefly, this example displays a number of features outlined above. First, the patient 
offers a delayed and short reply ("I worked") to the neurologist’s question about their 
post-school activities. This question gives the patient the opportunity to expand on 
her answer (as seen in Figure 7 with the FMD patient) and the neurologist’s follow-
up questions indicate a similar orientation. However, the patient struggles to provide 
any further detail (notice the long gaps) and agrees that they cannot "remember".  
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4. Discussion/Conclusion 
4.1 Discussion - Summary 
The principal aim of this research was to develop conversational profiles, which 
could help distinguish between the interactional behaviour of patients with FMD and 
that of patients with memory problems due to ND. We have identified and explored a 
range of conversational indicators that can aid the diagnostic process.  Patients with 
ND were more likely than those independently diagnosed with FMD to be 
accompanied during their visit to the memory clinic. The companions of patients with 
ND were more likely to be concerned about the patients’ memory difficulties than 
patients themselves; by contrast FMD patients who were accompanied were, when 
asked, always more concerned than their companions. Even when accompanied to 
the clinic, patients with FMD only rarely sought their companions’ assistance in 
answering questions; conversely, patients with dementia relied to a very large extent 
on their companions’ assistance in answering. Patients with ND struggled to answer 
specific questions in much detail (if at all), had difficulties responding to compound 
questions, frequently responded "I don't know" when unable to recall information, 
and generally had difficulties sustaining the interaction - their memory failure 
impacting significantly on their ability to communicate with the neurologist during the 
outpatient clinic encounter [51-54]. Patients with FMD on the other hand interacted 
much more confidently with the neurologists, could provide numerous extended and 
specific examples of memory difficulties, give detailed answers going beyond the 
parameters of the question and they could handle and recall all parts of compound 
questions. Future research will be undertaken to confirm the diagnostic sensitivity 
and specificity of the different interactional features described here and that of the 
conversation profiles as a whole. This will be done by blind testing – coding a sample 
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of history-taking interactions for which the clinical diagnosis is known, but not 
revealed to the coders, in order to test the effectiveness of the conversational profile 
emerging in predicting/identifying dementia and FMD. 
4.2 Conclusion - Study limitations 
The limitations of our study include the following: the conversational profile we report 
was based upon a relatively small sample size drawn from patients attending a 
single memory clinic in Sheffield, UK. Small datasets are common for conversation 
analytic research of this kind based on the detailed and extensive analysis of 
recorded data and associated transcripts [18]. Whilst the findings described were 
seen in the majority of cases in both diagnostic groups, they should be confirmed in 
larger future studies. The issue of sample size is particularly relevant with regard to 
accompanying persons. Ideally we would have a large number of interactions with 
APs and a large number without in both diagnostic groups to enable the comparison 
of the interactional features. 
The differentiating diagnostic value of our interactional and linguistic observations 
should be confirmed a) in a future prospective study in which the analyst is unaware 
of the clinical diagnosis at the time of analysis, and b) for patients speaking 
languages other than English (who may communicate differently with health 
professionals) [55, 56]. 
Whilst our approach using CA on memory clinic data has yielded a number of 
observations, which may help healthcare practitioners with the diagnostic process in 
the memory clinic, our list of potentially differentiating features is unlikely to be 
complete. The more extensive research that has been carried out on seizure clinic 
encounters has revealed that other linguistic techniques (including metaphor 
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analysis, focussed content analysis or phonological studies) and statistical methods 
can yield additional insights [17, 57, 58].  Additional diagnostic pointers may also be 
described using CA, for instance by focussing more on the contributions of 
accompanying persons.  
4.3 Practice implications 
Despite these limitations, our findings demonstrate that a conversation profile of 
patients’ contributions to outpatient clinic encounters in the memory clinic has the 
potential to aid the diagnostic process [59]. Whilst our study was conducted in a 
hospital-based specialist memory clinic, these profiles could be useful in both 
primary and secondary care settings. Attending to conversational cues could aid the 
screening and referral process from primary care, which would be important in 
facilitating earlier diagnosis of ND without overwhelming specialist services.  
Beyond the issue of helping with the differential diagnosis, references to 
conversational observations in the explanation of the memory complaints given to 
the patient may make these explanations more acceptable or effective. For instance, 
a doctor may want to reassure a patient with FMD that they are unlikely to be 
experiencing symptoms of dementia because they were able to provide a lot of detail 
when relating experiences of apparent memory failures. Patients presenting with 
memory failure complaints may also experience the initial open discussion as less 
stressful and anxiety-provoking than other diagnostic processes, such as cognitive 
screening tools [19].  
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Table 1 
 
 
 
Table 1 - Patient details 
  FMD group ND group Difference 
Age Median (range) 60 (47-80) 66 (51-78) ns (p=.428) 1 
Education Median (range) 15 (10-17) 14.5 (10-16) ns (p=1.000) 1 
PHQ-9 Median (range) 6 (0-14) 2.5 (1-22) ns (p=.688) 1 
GAD-7 Median (range) 4 (0-11) 3.5 (0-18) ns (p=1.000) 1 
% 
accompanied 
Percentage 40.0% 90.9% P<0.0082 
% female Percentage 66.70% 45.50% ns (p=.689)2 
1Fischer Exact Significance; 2Chi-Square test 
 
Notes 
Education: 
Measured in total years in education 
PHQ-9 Depression Severity scoring:  
0-5 = mild; 6-10 = moderate; 11-15 = moderately severe; 16-20 = severe depression 
GAD-7 Anxiety Severity scoring:  
0-5 mild; 6-10 moderate; 11-15 moderately severe anxiety; 15-21  severe anxiety 
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Figures 1-8 
 
Figure 1 - 048 (dementia, accompanied) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Neu 
 
 
AP 
 
 
 
Neu 
Um- (5) Do you know the reasons why you've been referred to this clinic 
and, and who's more concerned. 
(0.7) 
((Coughs)) Right, well- ((coughs)) sorry (0.5) um I'll, I'll explain that er 
when (.) ((Patient name)) had um, when she was um ((tuts)) (0.5) she left 
work in 2011 about er- I got her to er- in February about 2011 to see the 
GP because she was having (.) er problems at work. 
Mm hmm, 
((conversation between Neu and AP continues in similar pattern)) 
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Figure 2 - 034 (FMD, accompanied) 
1 
2 
3 
4 
5 
Neu 
Pat 
 
AP 
Neu 
 And er meeting your wife? 
Yes I can remember meeting my wife (.) bowling alley ((turns to 
AP))[yeah. 
       [((nods)) 
So, er and then: getting married? 
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Figure 3 - 040 (FMD, unaccompanied) 
1 
2 
3 
4 
5 
6 
7 
8 
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10 
11 
12 
13 
Neu 
Pat 
Neu 
Pat 
Yeah (2) Um, and can you (.) tell me the last time it happened to you? 
Er, yesterday, yesterday, yeah= 
=And what happened?  
Um, I- I was um, we were out walking with, with friends and um we were 
having a conversation (.) and er- we were talking about the economy, 
a:nd um (1.3) I- I was having the conversation (.) I was talking about 
Italy, I remember it exactly, talking about Italy, and I got to the- to the 
word economy and I couldn't remember it, <I couldn't remember the word 
economy>, and my sentence, everything just stopped, it was like phew 
((hands motion hitting a wall)) (1.6) and everybody went (1) "And?" (0.9)  
And I- I just- well I just stood there, what- what- I just couldn't get 
anything out, couldn't (.) <I couldn't think of the word> economy 
((continues)) 
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Figure 4 - 056 (dementia, accompanied) 
1 
2 
3 
4 
5 
6 
7 
8 
Neu 
Pat 
 
AP 
 
 
Neu 
Pat 
How's er: reading, writing, spelling? 
Erm (.) <reading> (.) I read an awful lot (.) however, I have- and the only 
way I've noticed it is, well we've got a three year old grandson and I= 
= Oh yeah. 
((27 lines of talk lasting 51 seconds about the patient's difficulties reading 
stories omitted)) 
OK. How's your spelling writing? 
I think me- writing's deteriorated (.) Um (1.5) spelling? 
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Figure 5 - 048 (dementia, accompanied) 
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21 
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Pat 
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Pat 
 
Neu 
 
 
Neu 
Pat 
Neu 
 
Pat 
AP 
Neu 
 
Pat 
Where's your favourite place that you've been in the world? 
(2.4) 
Oh it's hard to say isn't it? ((laughter)) 
If you had to have maybe your top five then? 
(1.8) 
Top five? ((turns to AP and back)) 
Which of your journeys or travels sort of stands out most? 
Latin America. 
And whereabouts in Latin America did you go? 
All over. 
(2.6) 
Can you tell me which- which of those countries, which ones did you 
visit? 
(3.6) 
And were you travelling on your own or, were you in a group, or, 
With my husband most of the [time. 
                                                [Right. And how many years ago was that? 
(2.0) 
Two three, ((turn to AP)) more? 
A bit more than that, yeah. 
OK. Can you remember any, the names of any places you went to or 
what you saw? 
Not offhand. (2.0) Went all over, you see. ((laughter)) 
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Figure 6 - 033 (dementia, accompanied) 
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Pat 
 
AP1 
Pat 
 
And could you, give me an example of the last time your memory, let you 
down? 
(1.5) 
Um: ((turn to AP1)) 
(2.8) 
In the car you've lost your sense of direction (.) does that count? 
Right ((nods)) 
((Pat and AP1 laugh)) 
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Figure 7 - 004 (FMD, unaccompanied) 
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3 
4 
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Neu 
Pat 
 
Neu 
Pat 
So where are you from originally? 
Um, I come from ((Country name)) (.) but I was, my father was a 
missionary in India and I was there until I was fourteen= 
Mm hmm. 
=So I came back from India when I was fourteen in 1948 (0.6) um then I 
went to university in ((City name)). 
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Figure 8 - 048 (Dementia, accompanied) 
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Neu 
Pat 
Neu 
 
Neu 
 
Pat 
Neu 
And what did you do first after leaving school? 
(2.5) 
Did you go onto college or: did you work or- 
Yeah, I worked.  
And what was your first job after leaving school?  
(6.7) 
Can you remember what your first job was?  
(2.9) 
Not offhand. 
Okay. 
 
 
